BA
ALIM

BlackRock Advisors’s Alimera Sciences ALIM Stock Holding History

BlackRock Advisors’s Portfolio ALIM Stock Details ALIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$8K Hold
498
– – ﹤0.01% 3595
2016
Q3 		$11K Hold
498
– – ﹤0.01% 3566
2016
Q2 		$9K Sell
498
-542
-52% -$14.4K ﹤0.01% 3595
2016
Q1 		$27K Hold
1,040
– – ﹤0.01% 3365
2015
Q4 		$38K Sell
1,040
-473
-31% -$20.5K ﹤0.01% 3298
2015
Q3 		$50K Buy
1,513
+201
+15% +$11.3K ﹤0.01% 3318
2015
Q2 		$91K Buy
1,312
+270
+26% +$18.6K ﹤0.01% 3202
2015
Q1 		$78K Buy
1,042
+193
+23% +$15.2K ﹤0.01% 3141
2014
Q4 		$71K Buy
849
+125
+17% +$10.1K ﹤0.01% 3191
2014
Q3 		$59K Hold
724
– – ﹤0.01% 3230
2014
Q2 		$65K Buy
724
+119
+20% +$10.6K ﹤0.01% 3210
2014
Q1 		$72K Buy
605
+47
+8% +$4.57K ﹤0.01% 3159
2013
Q4 		$39K Buy
558
+22
+4% +$897 ﹤0.01% 3285
2013
Q3 		$30K Buy
536
+25
+5% +$1.57K ﹤0.01% 3262
2013
Q2 		$37K Buy
+511
New +$29.5K ﹤0.01% 3212

Other funds holding ALIM

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
NRC
North Run Capital Boston, Massachusetts $43.5M AUM 38.24% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return

BlackRock Advisors's ALIM Position: Q4 2016 in Review

BlackRock Advisors held its Alimera Sciences (ALIM) position steady in Q4 2016 at 498 shares worth $8K. The position accounts for ﹤0.01% of the portfolio, ranked #3595.

BlackRock Advisors first reported a position in ALIM in Q2 2013 and has held it in 15 quarters since. The position peaked at $91K in Q2 2015. 47 funds tracked by Wall St. Rank hold ALIM as of Q4 2016.

  • BlackRock Advisors held 498 shares of Alimera Sciences worth $8K as of Q4 2016.
  • BlackRock Advisors left its Alimera Sciences share count unchanged in Q4 2016.
  • Alimera Sciences made up ﹤0.01% of BlackRock Advisors's portfolio in Q4 2016, its #3595 holding.
  • BlackRock Advisors first reported a position in Alimera Sciences in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Advisors's Alimera Sciences position peaked at $91K in Q2 2015.
  • 47 funds tracked by Wall St. Rank held Alimera Sciences as of Q4 2016.

Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.